Navigation Links
PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration
Date:9/2/2009

SOUTH PLAINFIELD, N.J., Sept. 2 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced that Celgene Corporation has exercised its option to collaborate on advancing drug discovery efforts on an oncology target addressed through the application of PTC's GEMS(TM) (Gene Expression Modulation by Small-molecules) technology.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )

In September 2007, Celgene made a $20 million equity investment in PTC, which included an option for an exclusive research agreement. Under the terms of the research collaboration agreement, PTC will receive substantial milestone payments for achieving certain discovery, development, regulatory and commercial objectives.

"Celgene's decision to exercise the research option is a wonderful endorsement of our GEMS technology. Celgene is widely recognized for developing novel therapies in areas of high unmet medical need and we look forward to working together to advance this project," said Stuart Peltz, Ph.D., president and CEO of PTC Therapeutics.

About GEMS(TM)

Gene Expression Modulation by Small-molecules (GEMS) is PTC's novel and proprietary technology platform for the identification of small-molecules that modulate post-transcriptional control mechanisms. Compounds identified through the GEMS technology target processes that act through the untranslated regions (UTRs) of messenger RNA (mRNA) molecules. PTC has successfully employed the GEMS technology in drug discovery programs in oncology, infectious diseases, cardiovascular diseases, and neuromuscular disorders with corporate partners such as Celgene, Gilead, Parent Project Muscular Dystrophy, Pfizer, and Schering-Plough.

About PTC Therapeutics

PTC is a biopharmaceuti
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PTC Therapeutics Announces Drug Discovery Collaboration With Roche
2. United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend
3. Oxygen Biotherapeutics, Inc. to Present at Investment Conferences in New York and Zurich
4. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
5. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
6. Cell Therapeutics, Inc. Announces Closing of Registered Offering of $30 Million of Preferred Stock and Warrants
7. Cell Therapeutics, Inc. Announces Institutional Investor Purchases $30 Million of Preferred Stock and Warrants
8. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2009
10. Oxygen Biotherapeutics, Inc. Files 10-K for Fiscal Year Ended April 30, 2009
11. Cephalon Completes Acquisition of Arana Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...  Decision Resources Group finds that the majority ... the United States believe that ... be the level of savings achievable by their ... cost to patients. Payers plan to leverage preferential ... expectations in order to encourage physician prescribing of ...
(Date:7/30/2014)... Switzerland (PRWEB) July 30, 2014 ... technologies for biologic drug discovery and mammalian cell line ... SURE CHO-Mplus Libraries ™ will be presented at the ... being held, September 8 – 10, 2014 at ... California. , The following abstract will be presented ...
(Date:7/30/2014)... MA (PRWEB) July 30, 2014 BCC ... Global Markets for Enzymes in Industrial Applications , ... reach to nearly $7.1 billion by 2018, registering a ... growth is estimated to be recorded in the detergent ... forecast period. , Enzyme technology has influenced almost every ...
(Date:7/30/2014)... Md. , July 30, 2014 ... components to interrogate biology, but such devices can ... As such, researchers have looked ... in vitro metabolic engineering to characterize ... a chip. New devices are envisioned to recreate ...
Breaking Biology Technology:Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4
... Outcomes in Diabetic Patients, NATICK, Mass. and ... BSX ) today announced one-year results,from the ... OLYMPIA,registry. The first 7,124 patient cohort of the ... TAXUS(R) Liberate(TM) coronary stent,system in complex, real-world patients, ...
... A vaccine against anthrax that is more effective and ... effective in tests in mice and guinea pigs, report University ... Infection and Immunity. , The scientists were able to ... the animals noses with a nanoemulsion a suspension of ...
... NASA clean rooms, where scientists and engineers assemble ... deep mines as unlikely places where scientists have ... species of bacteria uncovered in a recent NASA ... According to Dr. Kasthuri Venkateswaran, who led the ...
Cached Biology Technology:Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 2Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 3Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 4Anthrax vaccine produces immunity with nanoparticles, not needles 2Anthrax vaccine produces immunity with nanoparticles, not needles 3NASA study will help stop stowaways to Mars 2
(Date:7/30/2014)... what they eat, the Food and Drug Administration (FDA) ... Facts label found on nearly every food product in ... News (C&EN), the weekly news magazine of the ... the fight that has ensued. , Britt Erickson, a ... Nutrition Facts label has remained largely the same for ...
(Date:7/30/2014)... been awarded the Scientific Committee on Antarctic Research,s ... , SCAR, an inter-disciplinary international science body, initiates, ... in the Antarctic region, and on the role ... The organisation also provides scientific advice about Antarctica ... the region. , The medal is open internationally ...
(Date:7/30/2014)... multitude of cells types. Researchers would like to understand how ... cells that make up the organs and other structures of ... chains of sugars that dangle from proteins on surfaces of ... San Diego, has created synthetic molecules that can stand in ... to direct the process, they report in the Journal ...
Breaking Biology News(10 mins):
... day die from breast cancer in the United States. ... taking hormone replacement therapy to avoid the effects of ... Hyder may lead to treatments for breast cancers associated ... international team, found that hormone-therapy-related breast cancer cells have ...
... extensive joint research project among two American Indian tribes ... A. Fulton Schools of Engineering at Arizona State University ... the Phoenix Metropolitan area has received a national environmental ... was awarded a 2013 National Environmental Excellence Award by ...
... new study raises concerns about possible health impacts of very ... international aid agencies are promoting to replace open-fire cooking in ... Science & Technology . Brian Just and colleagues ... on stoves or open fires that burn wood, animal dung ...
Cached Biology News:Joint air toxics research project among tribes, agencies recognized for partnership 2Joint air toxics research project among tribes, agencies recognized for partnership 3
... V, is used for protein separation and ... system includes both the mini (18 ml) ... harvesting apparatus, cooling finger, electrode chambers, 10 ... syringe, colored protein sample, 2 vent buttons, ...
...
... Labeling Kit - NH2 is primarily used ... immunostaining and cellular proteins for tracing. NH2-Reactive ... succinimidyl group (NHS), and can easily make ... IgG or other proteins without any activation ...
... Lines ,High Quality, Functionally-Validated, Ion Channel Cell ... for having a critical role in nerve ... key function in pain, CNS and the ... been investigated in therapeutic areas, such as ...
Biology Products: